Patent · US Active

Multispecific antigen binding proteins

US11208480B2 · kind B2 · utility

2Cited by

17References

8Claims

0Family size

Assignee

INNATE PHARMA · FR

Inventors

Laurent Gauthier · Toulouse, FR
Benjamin Rossi · Marseilles, FR

Key dates

Filing date	Jun 23, 2015
Grant date	Dec 28, 2021
Priority date	—
Expiry date	Feb 4, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Multimeric multispecific proteins formed from dimerization between CH1 and CK domains and that bind two target antigens are provided. The proteins have advantages in production and in the treatment of disease, notably cancer or infectious disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.